Suppr超能文献

根据不同标准对代谢健康但肥胖(MHO)中年男性的代谢特征进行比较。

Comparison of Metabolic Characteristics of Metabolically Healthy but Obese (MHO) Middle-Aged Men According to Different Criteria.

作者信息

Yoo Ho Kwon, Choi Eun Young, Park Eal Whan, Cheong Yoo-Seock, Bae Ri Ah

机构信息

Department of Family Medicine, Dankook University College of Medicine, Cheonan, Korea.

出版信息

Korean J Fam Med. 2013 Jan;34(1):19-26. doi: 10.4082/kjfm.2013.34.1.19. Epub 2013 Jan 28.

Abstract

BACKGROUND

To compare the prevalence and metabolic characteristics of metabolically healthy but obese (MHO) individuals according to different criteria.

METHODS

We examined 186 MHO middle-aged men (age, 37.2 years; body mass index [BMI], 27.2 kg/m(2)). The following methods were used to determine MHO: the National Cholesterol Education Program (NCEP) Adult Treatment Panel III criteria, 0-2 cardiometabolic abnormalities; the Wildman criteria, 0-1 cardiometabolic abnormalities; the Karelis criteria, 0-1 cardiometabolic abnormalities; the homeostasis model assessment [HOMA] criteria (lowest quartile of HOMA). After dividing the overall subjects into two age groups, we compared the prevalence and clinical characteristics between MHO and at-risk groups according to four different criteria.

RESULTS

The prevalence of MHO using the NCEP, Wildman, Kaleris, and HOMA criteria were 70.4%, 59.7%, 28.5%, and 24.2%, respectively. The agreement between the groups according to the NCEP and Wildman criteria was substantial (kappa = 0.8, P < 0.001). Among individuals 35 years or younger, and regardless of method, the MHO subjects had significantly lower weight, waist circumference, BMI, body fat percentage, insulin, HOMA, alanine aminotransferase, triglyceride (TG), and TG/high density lipoprotein cholesterol (HDL-C) ratio than the at-risk subjects (P < 0.05); However, among individuals older than 35 years old, and regardless of method, the MHO subjects had different insulin, HOMA, HDL-C, and TG/HDL-C levels than the at-risk subjects (P < 0.05).

CONCLUSION

The differences in metabolic profile between MHO and at-risk groups varied according to age. MHO prevalence varies considerably according to the criteria employed. Expert consensus is needed in order to define a standardized protocol for determining MHO.

摘要

背景

根据不同标准比较代谢健康但肥胖(MHO)个体的患病率及代谢特征。

方法

我们对186名中年男性MHO患者(年龄37.2岁;体重指数[BMI]为27.2kg/m²)进行了检查。采用以下方法确定MHO:美国国家胆固醇教育计划(NCEP)成人治疗小组第三次报告标准,即0 - 2项心血管代谢异常;怀尔德曼标准,即0 - 1项心血管代谢异常;卡雷利斯标准,即0 - 1项心血管代谢异常;稳态模型评估[HOMA]标准(HOMA最低四分位数)。将所有受试者分为两个年龄组后,我们根据四种不同标准比较了MHO组和风险组之间的患病率及临床特征。

结果

采用NCEP、怀尔德曼、卡雷利斯和HOMA标准时,MHO的患病率分别为70.4%、59.7%、28.5%和24.2%。根据NCEP和怀尔德曼标准划分的组间一致性较高(kappa = 0.8,P < 0.001)。在35岁及以下个体中,无论采用何种方法,MHO受试者的体重、腰围、BMI、体脂百分比、胰岛素、HOMA、丙氨酸转氨酶、甘油三酯(TG)以及TG/高密度脂蛋白胆固醇(HDL-C)比值均显著低于风险组受试者(P < 0.05);然而,在35岁以上个体中,无论采用何种方法,MHO受试者的胰岛素、HOMA、HDL-C以及TG/HDL-C水平与风险组受试者存在差异(P < 0.05)。

结论

MHO组和风险组之间的代谢特征差异随年龄而异。MHO患病率根据所采用的标准有很大差异。需要专家共识来定义确定MHO的标准化方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aca/3560335/411fccfdda24/kjfm-34-19-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验